Skip to main content
SpringerLink
Log in

PAF Antagonists

Their Potential Therapeutic Role in Asthma

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Amoux B, Denjean A, Page CP, Morley J, Benveniste J. Pulmonary effects of platelet-activating factor in a primate are inhibited by ketotifen. American Review of Respiratory Diseases 131: 2, 1985

    Google Scholar 

  • Arnoux B, Joseph M, Simoes AH, Tonnel AB, Duroux P, et al. Antigenic release of PAF-acether and beta-glucuronidase from alveolar macrophages of asthmatics. Bulletin Européen de Physiopathologie Respiratoire 23: 119–124, 1987

    PubMed  CAS  Google Scholar 

  • Aursudkij B, Rogers DF, Evans TW, Alton EWFW, Chung KF, et al. Reduced tracheal mucus velocity in guinea-pig in vivo by platelet activating factor. American Review of Respiratory Diseases 35: 160, 1987

    Google Scholar 

  • Barnes PJ. Cell receptors and airway function. In Flenley & Petty (Eds) Recent advances in respiratory medicine IV, pp. 25–44, Churchill Livingstone, London, 1986a

    Google Scholar 

  • Barnes PJ. Asthma as an axon reflex. Lancet 1: 242–245, 1986b

    PubMed  CAS  Google Scholar 

  • Barnes PJ. The changing face of asthma. Quarterly Journal of Medicine 63: 359–365, 1987a

    PubMed  CAS  Google Scholar 

  • Barnes PJ, Chung KF, Page CP. Platelet-activating factor as a mediator of allergic disease. Journal of Allergy and Clinical Immunology. In press, 1987b

  • Barnes PJ, Cuss FMC, Palmer JBD. The effect of airway epithelium on smooth muscle contractility in bovine trachea. British Journal of Pharmacology 86: 685–691, 1985

    PubMed  CAS  Google Scholar 

  • Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax 39: 500–504, 1984

    PubMed  CAS  Google Scholar 

  • Basran GS, Page CP, Paul W, Morley J. Cromoglycate (DSCG) inhibits responses to platelet activating factor (Paf-acether) in man: an alternative mode of action for DSCG in asthma? European Journal of Pharmacology 86(1): 143–144, 1983

    Google Scholar 

  • Benveniste J, Henson PM, Cochrane CG. Leucocyte dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet activating factor. Journal of Experimental Medicine 136: 1356–1377, 1972

    PubMed  CAS  Google Scholar 

  • Boulet LP, Cartier A, Thomson NC, Roberts RS, Dolovich J, et al. Asthma and increases in non-allergic bronchial responsiveness from seasonal pollen exposure. Journal of Allergy and / Clinical Immunology 71: 399–404, 1983

    CAS  Google Scholar 

  • Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. American Review of Respiratory Diseases 121: 389–413, 1980

    CAS  Google Scholar 

  • Braquet P, Spinnewyn B, Braquet M, Bourgain RH, Taylor JE, et al. BN 52021 and related compounds: a new series of highly specific PAF-receptor antagonists isolated from Ginkgo biloba. Blood Vessels 16: 559–572, 1985

    Google Scholar 

  • Britton JR, Hanley SP, Tattersfield AE. The effect of an oral leukotriene D4 antagonist L-649, 923 on the response to inhaled antigen in asthma. Journal of Allergy and Clinical Immunology 79: 811–815, 1987

    PubMed  CAS  Google Scholar 

  • Burney PGJ. Asthma mortality in England and Wales: evidence for a further increase. Lancet 2: 323–326, 1986

    PubMed  CAS  Google Scholar 

  • Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, et al. The release of platelet activating factor from human endothelial cells in culture. Journal of Immunology 131: 2397–2403, 1983

    CAS  Google Scholar 

  • Casals-Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet-activating factor, in endotoxin shock. European Journal of Pharmacology 135: 117–122, 1987

    PubMed  CAS  Google Scholar 

  • Casals-Stenzel J, Weber KH. Triazolobenzodiazepines: dissociation of their Paf (platelet-activating factor) antagonistic and CNS activity. British Journal of Pharmacology 90: 139–146, 1987

    PubMed  CAS  Google Scholar 

  • Chignard M, LeCouedic JP, Vargaftig BB, Benveniste J. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. British Journal of Haematology 46: 455–464, 1980

    PubMed  CAS  Google Scholar 

  • Chung KF. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41: 657–662, 1986

    PubMed  CAS  Google Scholar 

  • Chung KF, Aizawa H, Leikauf GD, Ueki IF, Evans TW, et al. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. Journal of Pharmacology and Experimental Therapeutics 236: 580–584, 1986

    PubMed  CAS  Google Scholar 

  • Chung KF, Barnes PJ. Bronchial hyperreactivity induced by platelet-activating factor (PAF): modification by a beta-agonist. Thorax 42: 220, 1987

    Google Scholar 

  • Chung KF, Dent G, McCusker M, Guinot Ph, Page CP, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1: 248–251, 1987d

    PubMed  CAS  Google Scholar 

  • Chung KF, Dixon CMS, Barnes PJ. Platelet-activating factor (PAF) and asthmatic airways: effects of caliber, responsiveness and circulating cells. American Review of Respiratory Diseases 135: 159, 1987b

    Google Scholar 

  • Chung KF, McCusker M, Minette P, Barnes PJ. Ketotifen inhibits the cutaneous responses but not the bronchoconstriction and bronchial hyperresponsiveness induced by PAF in man. Thorax 42: 220, 1987c

    Google Scholar 

  • Clark RAF, Sandler JA, Gallin JI, Kaplan AP. Histamine modulation of eosinophil migration. Journal of Immunology 118: 137–145, 1977

    CAS  Google Scholar 

  • Clay KL, Murphy RC, Andres JL, Lynch J, Henson PM. Structure elucidation of platelet activating factor derived from human neutrophils. Biochemical and Biophysical Research Communications 121: 815–825, 1984

    PubMed  CAS  Google Scholar 

  • Cockcroft DW, Ruffm RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clinical Allergy 7: 503–513, 1977

    PubMed  CAS  Google Scholar 

  • Coyle A, Page CP, Touvay C, Villain B, Braquet P. Effect of the selective PAF antagonist BN 52021 on antigen-induced bronchial hyperreactivity in the guinea-pig. American Review of Respiratory Diseases 135: A161, 1987a

    Google Scholar 

  • Coyle AJ, Sjoerdsma K, Page CP, Brown L, Metzger WJ. Modification of the late asthmatic response and bronchial hyperreactivity in the allergic rabbit by the specific PAF antagonist, BN 52063. Journal of Allergy and Clinical Immunology. In press, 1987b

  • Cuss FM, Dixon CMS, Barnes PJ. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2: 189–192, 986

  • Dahlen S-E, Bjork J, Hedquist P, Arfors KE, Hammarstrom S, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proceedings of the National Academy of Sciences (USA) 78: 3887–3891, 1981

    CAS  Google Scholar 

  • Darius H, Lefer DJ, Smith B, Lefer AM. Role of platelet-activating factor — acether in mediating guinea pig anaphylaxis. Science 232: 58–60, 1986

    PubMed  CAS  Google Scholar 

  • Davidson AB, Lee TH, Scamon PD, Solway J, McFadden ER, et al. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. American Review of Respiratory Diseases 135: 333–337, 1987

    CAS  Google Scholar 

  • Davies RJ, Green M, Schofield NM. Recurrent nocturnal asthma after exposure to grain dust. American Review of Respiratory Diseases 114: 1011–1019, 1976

    CAS  Google Scholar 

  • De Monchy JGR, Kauffman HF, Venge P, Koeter GH, Jansen HM, et al. Bronchoalveolar eosinophils during allergen-induced late asthmatic reactions. American Review of Respiratory Diseases 131: 373–376, 1985

    Google Scholar 

  • Denjean A, Arnoux B, Masse R, Lockhart A, Benveniste J. Acute effects of intratracheal administration of platelet-activating factor in baboons. Journal of Applied Physiology 55: 799–804, 1983

    PubMed  CAS  Google Scholar 

  • Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, et al. Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats: studies with PAF-receptor antagonist Kadsurenone. Biochemical and Biophysical Research Communications 127: 799–808, 1985

    PubMed  CAS  Google Scholar 

  • Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. Journal of Clinical Pathology 13: 27–33, 1960

    PubMed  CAS  Google Scholar 

  • Evans TW, Brokaw JJ, Chung KF, McDonald DM, Nadel JA. Ozone-induced bronchial hyperreactivity and airway inflammation in the rat. Clinical Science 70: 67P, 1985

    Google Scholar 

  • Evans TW, Chung KF, Rogers DF, Barnes PJ. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. Journal of Applied Physiology 63: 479–484, 1987a

    PubMed  CAS  Google Scholar 

  • Evans TW, Rogers DF, Dent G, Aursudkij B, Chung KF, et al. Effects of platelet-activating factor (PAF) antagonist (WEB 2086) on airway microvascular leakage induced by PAF and antigen. American Review of Respiratory Diseases 135: A162, 1987c

    Google Scholar 

  • Evans TW, Rogers DF, Roberts NM, Chung KF, Barnes PJ. Mediators of increased vascular permeability during anaphylaxis in sensitised guinea-pigs. Thorax 42: 221, 1987b

    Google Scholar 

  • Fairfax AJ, Hanson JM, Morley J. The late reaction following bronchial provocation with house dust mite allergen: dependence on arachidonic acid metabolism. Clinical and Experimental Immunology 53: 393–398, 1983

    Google Scholar 

  • Fitzgerald MF, Moncada S, Parente L. The anaphylactic release of platelet-activating factor from perfused guinea pig lungs. British Journal of Pharmacology 88: 149–153, 1986

    PubMed  CAS  Google Scholar 

  • Flavahan NA, Aarhus LL, Rimele TJ, Vanhoutte PM. Respiratory epithelium inhibits bronchial smooth muscle tone. Journal of Applied Physiology 58: 834–838, 1985

    PubMed  CAS  Google Scholar 

  • Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. British Medical Journal 294: 279–283, 1987

    PubMed  CAS  Google Scholar 

  • Flint KC, Leung KBP, Hudspith BN, Brostoff J, Pearce FL, et al. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. British Medical Journal 291: 923–926, 1985

    PubMed  CAS  Google Scholar 

  • Frigas E, Gleich GJ. The eosinophil and the pathology of asthma. Journal of Allergy and Clinical Immunology 77: 527–537, 1986

    PubMed  CAS  Google Scholar 

  • Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, et al. Effects of thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 41: 955–959,1986

    PubMed  CAS  Google Scholar 

  • Fuller RW, Dixon CMS, Dollery CT, Barnes PJ. Prostaglandin D2 potentiates airway responses to histamine and methacholine. American Review of Respiratory Diseases 133: 252–254, 1986

    CAS  Google Scholar 

  • Gateau O, Arnoux B, Deriaz H, Viars P, Benveniste J. Acute effects of intratracheal administration of Paf-acether (platelet-activating factor) in humans. American Review of Respiratory Diseases 3: 129, 1984

    Google Scholar 

  • Glynn AA, Michaels L. Bronchial biopsy in chronic bronchitis and asthma. Thorax 15: 142–153, 1960

    CAS  Google Scholar 

  • Godard P, Chaintreuil J, Damon M, Coupe M, Flandre O, et al. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. Journal of Allergy and Clinical Immunology 70: 88–93, 1982

    PubMed  CAS  Google Scholar 

  • Goetzl EJ, Austen KF. Purification and synthesis of eosinophil-otactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proceedings of the National Academy of Sciences (USA) 72: 4123–4127, 1975

    CAS  Google Scholar 

  • Griffin M, Weiss JW, Leitch AG, McFadden ER, Corey EJ, et al. Effect of leukotriene D4 on the airways in asthma. New England Journal of Medicine 308: 436–439, 1983

    PubMed  CAS  Google Scholar 

  • Guinot Ph, Braquet P, Duchier J, Cournot A. Inhibition of PAF-acether induced wheal and flare reaction in man by a specific antagonist. Prostaglandins 32: 160–163, 1986

    PubMed  CAS  Google Scholar 

  • Halonen M, Lohman IC, Dunn AM, McManus LM, Palmer JD. Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. American Review of Respiratory Diseases 131: 11–17, 1985

    CAS  Google Scholar 

  • Halonen M, Palmer JD, Lohman IC, McManus LM, Pinckard RN. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. American Review of Respiratory Diseases 122: 915–924, 1980

    CAS  Google Scholar 

  • Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annual Review of Biochemistry 55: 483–509, 1986

    PubMed  CAS  Google Scholar 

  • Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. New England Journal of Medicine 311: 209–213, 1984

    PubMed  CAS  Google Scholar 

  • Haroldsen PE, Voelkel NF, Henson JE, Henson PM, Murphy RC. Metabolism of platelet-activating factor in isolated perfused rat lung. Journal of Clinical Investigation 79: 1860–1867, 1987

    PubMed  CAS  Google Scholar 

  • Henocq E, Vargaftig BB. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet 1: 1378–1379, 1986

    PubMed  CAS  Google Scholar 

  • Houston JC, de Nevasquez S, Trounce JR. A clinical and pathologic study of fatal cases of status asthmaticus. Thorax 8: 207–213,1953

    PubMed  CAS  Google Scholar 

  • Hwang MN, Chang ML, Garcia QQ, Huang L, King VF, et al. L-652,469 — A dual antagonist of platelet activating factor and dihydropyridines from Tussilogo furfara. European Journal of Pharmacology, in press, 1987

  • Hwang SB, Lam MH, Biftu T, Beattie TR, Shen TY. Trans-2, 5-Bis-(3,4,5,-trimethotyphenyl) tetrahydrofuran: an orally active specific and competitive receptor antagonist of platelet activating factor. Journal of Biological Chemistry 260: 15639–15645, 1985b

    PubMed  CAS  Google Scholar 

  • Hwang S-B, Lam M-H, Shen TY. Specific binding sites for platelet activating factor in human lung tissues. Biochemical and Biophysical Research Communications 128: 972–979, 1985a

    PubMed  CAS  Google Scholar 

  • Inarrea P, Gumez-Cambronero J, Nieto M, Sanchez-Crespo M. Characteristics of binding of platelet activating factor to platelets of different animal species. European Journal of Pharmacology 105: 309–315, 1984

    PubMed  CAS  Google Scholar 

  • Irvin CG, Berend N, Henson PM. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg. American Review of Respiratory Diseases 134: 777–783, 1986

    CAS  Google Scholar 

  • Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 36: 575–579,1981

    PubMed  CAS  Google Scholar 

  • Kornecki E, Garlich YH, Lenox RH. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines, Science 226: 1954–1956, 1985

    Google Scholar 

  • Lagente V, Touvay C, Randon J, Desquand S, Cirino M, et al. Interference of the Paf-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Prostaglandins, in press, 1987

  • Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. American Review of Respiratory Diseases 131: 599–606, 1985

    CAS  Google Scholar 

  • Lam S, Wong R, Chan-Yeung M. Non-specific bronchial reactivity in occupational asthma. Journal of Allergy and Clinical Immunology 63: 28–34, 1979

    PubMed  CAS  Google Scholar 

  • Latrigue-Mattei C, Godeneche D, Chabard JL, Petie J, Berger JA. Pharmacokinetic study of 3H-labelled Paf-acether. II: comparison with 3H-labelled lyso-Paf-acether after intravenous administration in the rabbit and protein binding. Agent and Actions 15: 643–648, 1984

    Google Scholar 

  • Lee TC, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet activating factor in activated human eosinophils. Journal of Biological Chemistry 259: 5526–5530, 1984

    PubMed  CAS  Google Scholar 

  • Lynch JM, Henson PM. The intracellular retention of newly-synthetized platelet-activating factor. Journal of Immunology 137: 2653–2661, 1986

    CAS  Google Scholar 

  • Marom Z, Shelhamer JH, Bach MR, Morton DR, Kalinen M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. American Review of Respiratory Diseases 126: 449–451, 1982

    CAS  Google Scholar 

  • Mazzoni L, Morley J, Page CP, Sanjar S. Induction of airway hyper-reactivity by platelet activating factor in the guinea-pig. Journal of Physiology 365: 107P, 1985a

    Google Scholar 

  • Mazzoni L, Morley J, Page CP, Sanjar S. Prophylactic anti-asthma drugs impair the airway hyperreactivity that follows exposure to platelet activating factor (PAF). British Journal of Pharmacology 86: 571P, 1985b

    Google Scholar 

  • McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. Journal of Clinical Investigation 76: 271–280, 1985

    PubMed  CAS  Google Scholar 

  • Moreno RH, Hogg JC, Pare PD. Mechanics of airway narrowing. American Review of Respiratory Diseases 133: 1171–1180, 1986

    CAS  Google Scholar 

  • Morley J, Page CP, Mazzoni L, Sanjar S. Effects of ketotifen upon responses to platelet activating factor: A basis for asthma prophylaxis. Annals of Allergy 56: 335–340, 1986

    PubMed  CAS  Google Scholar 

  • O’Bryne PM, Walters EH, Aizawa H, Fabbri LM, Holtzman MJ, et al. Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. American Review of Respiratory Diseases 130: 220–224, 1984

    Google Scholar 

  • O’Flaherty JT, Surles JR, Redman J, Jacobson D, Piantadosi C, et al. Binding and metabolism of platelet-activating factor by human neutrophils. Journal of Clinical Investigation 78: 381–388, 1986

    PubMed  Google Scholar 

  • O’Flaherty JT, Wykle RL. Biology and biochemistry of platelet-activating factor. Clinical Review in Allergy 1: 353–367, 1983

    Google Scholar 

  • Okamoto M, Yoshida K, Uchida I, Kohsaka M, Aoki H. Studies of platelet activating factor (PAF) antagonists from microbial products. II: pharmacological studies of FR-49175 in animal models. Chemical and Pharmaceutical Bulletin (Tokyo) 34: 345–348, 1986

    CAS  Google Scholar 

  • Partridge MR, Saunders KB. Effect of inhaled antihistamine (clemastine) as a bronchodilator and as a maintenance treatment in asthma. Thorax 34: 771–776, 1979

    PubMed  CAS  Google Scholar 

  • Persson CGA, Erjefalt I. Inflammatory leakage of macromol-ecules from the vascular compartment into the tracheal lumen. Acta Physiologica Scandinavica 126: 615–616, 1986

    PubMed  CAS  Google Scholar 

  • Persson CGA, Erjefalt I, Sundler F. Airway microvascular and epithelial leakage of plasma induced by PAF-acether (PAF) and capsaicin (CAP). American Review of Respiratory Diseases 135: A401, 1987

    Google Scholar 

  • Platts-Mills TAE, Mitchell EB, Nock P, Tovey ER, Moszoro H, et al. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 2: 675–677, 1982

    PubMed  CAS  Google Scholar 

  • Prescott SM, Zimmerman GA, Mclntyre TM. Human endothelial cells in culture produce platelet-activating factor (1-alkyl2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proceedings of the National Academy of Science (USA) 81: 3534–3538, 1984

    CAS  Google Scholar 

  • Roberts NM, Page CP, Chung KF, Barnes PJ. Effect of a PAF antagonist, BN52063, on antigen-induced acute and late-onset cutaneous responses in atopic subjects. Submitted, 1987

  • Rogers DF, Aursudkij B, Evans TW, Belvisi MG, Chung KF, et al. Platelet activating factor increases protein exudation but not mucus secretion in guinea-pig trachea in vivo. American Review of Respiratory Diseases 135: A160, 1987

    Google Scholar 

  • Schleimer RP, MacGlashan DW, Peters SP, Pinckard RN, Adkinson NF, et al. Characterization of inflammatory mediator release from purified human lung mast cells. American Review of Respiratory Diseases 133: 614–617, 1986

    CAS  Google Scholar 

  • Shen TY, Huang S-B, Chang MN, Doebber TW, Lam M-H, et al. Characterization of platelet-activating factor receptor antagonist isolated for haifenteng (Piper futokoedsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proceedings of the National Academy of Science 82: 672–676, 1985

    CAS  Google Scholar 

  • Shukla SD, Hanahan DJ. AGEPC (platelet activating factor) induced stimulation of rabbit platelets: effects on phosphatidylinositol, di and triphosphoinositides. Biochemical and Biophysical Research Communications 106: 697–703, 1982

    PubMed  CAS  Google Scholar 

  • Sly RM. Increases in death from asthma. Annals of Allergy 53: 20–25, 1984

    PubMed  CAS  Google Scholar 

  • Smith AP, Cuthbert MF, Dunlop LS. Effects of inhaled prostaglandins E1, E2, and p2α on the airway resistance of healthy and asthmatic man. Clinical Science and Molecular Medicine 48: 421–430, 1975

    PubMed  CAS  Google Scholar 

  • Snyder F. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline phospholipids. Medical Research Reviews 5: 107–140, 1985

    CAS  Google Scholar 

  • Soter NA, Lewis RA, Corey EJ, Auster KF. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. Journal of Investigative Dermatology 80: 115–119, 1983

    PubMed  CAS  Google Scholar 

  • Stevenson JS, Tallet M, Blinder B, Abraham WM. Modification of antigen-induced late responses with an antagonist of platelet-activating factor (WEB 2086). Abstract. Federation Proceedings 46: 1454, 1987

    Google Scholar 

  • Stewart CJ, Nunn AJ. Are asthma mortality rates changing? British Journal of Diseases of the Chest 79: 229–234, 1985

    PubMed  CAS  Google Scholar 

  • Terashita Z, Tsushima S, Yoshioka Y, Nomura H, Inada Y, et al. CV-3988, a specific antagonist of platelet activating factor (PAF). Life Sciences 32: 1975–1982, 1983

    PubMed  CAS  Google Scholar 

  • Touvay C, Etienne A, Braquet P. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific PAF-acether receptor antagonist isolated from Ginkgo biloba. Agents and Actions 17: 371–372, 1985

    CAS  Google Scholar 

  • Udaka K, Tatenchi Y, Movat H. Simple method for quantitation of enhanced vascular permeability. Proceedings of the Society for Experimental Biology and Medicine 133: 1384–1387, 1970

    PubMed  CAS  Google Scholar 

  • Valonne FH, Coles E, Reinhold VR, Goetzl EJ. Specific binding of phospholipid platelet-activating factor by human platelets. Journal of Immunology 129: 1637–1641, 1982

    Google Scholar 

  • Valonne FH, Goetzl EJ. Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-o-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology 48: 141–149, 1983

    Google Scholar 

  • Vargaftig BB, Lefort J, Chignard M, Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. European Journal of Pharmacology 65: 185–192, 1980

    PubMed  CAS  Google Scholar 

  • Vargaftig BB, Lefort J, Wal F, Chignard M, Medeiros MC. Interference of non-steroidal anti-inflammatory drugs associated to anti-histamine and anti-serotonin agents with the bronchial and platelet effects of‘platelet-activating factor’ (PAF-acether). European Journal of Pharmacology 82: 121–130, 1982

    PubMed  CAS  Google Scholar 

  • Walters EH, Parrish RW, Bevan C, Smith AP. Induction of bronchial hypersensitivity: evidence for a role of prostaglandins. Thorax 36: 571–574, 1981

    PubMed  CAS  Google Scholar 

  • Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. Journal of Clinical Investigation 78: 1701–1706, 1986

    PubMed  CAS  Google Scholar 

  • White J, Eiser NM. The role of histamine and its receptors in the pathogenesis of asthma. British Journal of Diseases of the Chest 77: 215–226, 1983

    PubMed  CAS  Google Scholar 

  • Williams BD, O’Sullivan MM, Saggu GS, Williams SKE, Williams LA, et al. Imaging in rheumatoid arthritis using liposomes labelled with technetium. British Medical Journal 293: 1143–1144, 1986

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Medicine, Cardiothoracic Institute, Brompton Hospital, Fulham Road, London, SW3 6HP, England

    K. F. Chung & P. J. Barnes

Authors
  1. K. F. Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. J. Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chung, K.F., Barnes, P.J. PAF Antagonists. Drugs 35, 93–103 (1988). https://doi.org/10.2165/00003495-198835020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835020-00001

Search

Navigation